1. What Is the Diabetes DTx Market?
The Diabetes DTx Market covers digital diabetes self-management programs, CGM-integrated decision support apps, and prevention platforms. Connected insulin pen data integration systems complete the core market scope. These digital tools support type 1 and type 2 diabetes management through behavioral coaching and data analytics. Core products include FDA-cleared diabetes management apps integrated with CGM data, structured digital diabetes education and lifestyle coaching programs, and automated insulin delivery system companion apps. Market dynamics reflect CGM adoption creating rich diabetes digital health data, T2D prevention digital program payer reimbursement, and type 1 AID system companion app demand. Diabetes DTx reduces HbA1c and improves time-in-range through behavioral and data-driven intervention.
2. Diabetes DTx Market Size & Forecast
3. Emerging Technologies
- Closed-loop artificial pancreas connected AID system companion apps advancing glycemic optimization are advancing. Growing T1D adoption is driven by Omnipod 5, Tandem Control-IQ, and Medtronic MiniMed app integration.
- GLP-1 agonist digital adherence coaching programs supporting Ozempic and Wegovy lifestyle optimization are advancing. Growing pharma partnership investment is driven by medication adherence improvement for GLP-1 patients.
- Social health community diabetes peer support digital platforms are advancing. Growing adoption is driven by peer accountability and community belonging improving diabetes self-management.
- AI endocrinologist assistant apps providing personalized insulin dosing advice are advancing. Growing adoption is driven by endocrinologist shortage and between-appointment self-management support.
Such innovations are driving change across adjacent industries too. Discover more in our Mental Health Dtx Market.
4. Key Market Opportunity
The primary opportunity in the Diabetes DTx Market is digital DPP payer reimbursement expansion. CGM-integrated behavioral coaching creates a premium diabetes digital health consumer and clinical market. GLP-1 adherence digital companion programs create a pharmaceutical partnership revenue opportunity. Asia Pacific diabetes DTx expansion in China, India, and Japan creates geographic opportunity.
5. Top Companies in the Diabetes DTx Market
The following organisations hold leading positions in the Diabetes DTx Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Omada Health
- Noom (Noom Med)
- Virta Health
- Livongo (Teladoc)
- Glooko
- One Drop
- January AI
- Levels
- Onduo (Sanofi digital health)
- Dario Health
6. Market Segmentation
The Diabetes DTx Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | CGM-Integrated Decision Support Diabetes Self-Management Programs Prevention Programs Insulin Dosing |
| By Indication | Type 1 Diabetes Type 2 Diabetes Prediabetes Prevention |
| By End User | Patients Endocrinologists PCPs Employers Health Plans Pharmacy Benefit Managers |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Diabetes DTx Market trajectory over the forecast period:
CGM Real-Time Glucose Data Is Creating a Digital Platform for Diabetes Behavioral Coaching.Continuous glucose monitor data streams enable real-time food-glucose response personalization coaching. Platforms like Levels, January AI, and Sweetrex link CGM glucose data to dietary behavior change. CGM-integrated coaching is advancing beyond diabetes patients to metabolic health consumer segments. CGM data integration is the most powerful diabetes digital health personalization signal.
CDC-Recognized Digital Diabetes Prevention Programs Are Generating Payer Reimbursement Revenue.Omada Health, Noom, and Virta Health are CMS-reimbursed digital DPP programs for T2D prevention. CMS Diabetes Prevention Program reimbursement covers digital and in-person lifestyle program delivery. Digital DPP programs demonstrate A1C reduction and weight loss comparable to in-person structured programs. Medicare and Medicaid digital DPP coverage is the primary payer reimbursement model in diabetes digital health.
Connected Insulin Pen Systems Are Advancing Type 1 Diabetes Dose Tracking and Safety.Bluetooth insulin pen caps and integrated smart pens transmit dose timing and amount to diabetes apps. Dose history integration with CGM data enables retrospective mealtime insulin adherence analysis. Missed dose alerts reduce insulin omission events associated with diabetic ketoacidosis risk. NovoPen Echo Plus, Tempo Pen, and InPen connected pen systems are advancing smart diabetes data ecosystems.
For related market intelligence, see the Prescription Digital Therapeutics Market.
8. Segmental Analysis
By type, the Diabetes Self-Management Program segment dominated the Diabetes DTx Market in 2025. Structured T2D lifestyle coaching and education represent the most widely deployed diabetes DTx category. The CGM-Integrated Decision Support segment is fastest-growing, driven by continuous glucose monitoring adoption.
9. Regional Analysis
Regional demand patterns across the Diabetes DTx Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Diabetes DTx Market in 2025 with a market share of 43.0%. The region hosts the largest digital DPP company base and CMS reimbursement framework. US CGM adoption rate creates the densest diabetes digital health real-world data ecosystem globally. Moreover, US endocrinologist shortage creates the strongest digital between-appointment management demand. DPP reimbursement, CGM adoption, and company concentration sustain North American dominance.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR of 29.96% in the Diabetes DTx Market through 2034. China's 140-million-plus T2D patient population creates the largest single diabetes digital health market. Japan's aging diabetes population and healthcare digitalization investment create strong DTx demand. Moreover, India's rapidly growing diabetes burden and smartphone penetration create DTx market opportunity. Diabetes prevalence, smartphone adoption, and healthcare digitalization position Asia Pacific for sustained outperformance.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Diabetes DTx Market was valued at USD 1.80 Bn in 2025 and is projected to reach USD 10.31 Bn by 2034, growing at a CAGR of 21.40% over the 2026–2034 forecast period.
The Diabetes DTx Market is projected to grow at a CAGR of 21.40% from 2026 to 2034.
North America dominated the Diabetes DTx Market in 2025 with a market share of 43.0%.
The leading companies in the Diabetes DTx Market include Omada Health, Noom (Noom Med), Virta Health, Livongo (Teladoc), Glooko, One Drop, January AI, Levels, Onduo (Sanofi digital health), Dario Health.
Cgm real-time glucose data is creating a digital platform for diabetes behavioral coaching.
By type, the Diabetes Self-Management Program segment dominated the Diabetes DTx Market in 2025.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.